183 related articles for article (PubMed ID: 12469191)
1. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue].
Tang L; Wang M; Ma J
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927
[TBL] [Abstract][Full Text] [Related]
5. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
6. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
Shigemasa K; Gu L; O'Brien TJ; Ohama K
Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; RosanĂ² L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
9. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
10. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer].
Guo GL; Yao ZX; Wu J
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1661-4. PubMed ID: 14642098
[TBL] [Abstract][Full Text] [Related]
12. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer.
Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ
J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
[TBL] [Abstract][Full Text] [Related]
18. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
19. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]